Targeting endothelial CD146 attenuates colitis and prevents colitis-associated carcinogenesis

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1604-1616

  Xing, Shu ^a   Luo, Yongting ^a   Liu, Zhihua ^a   Bu, Pengcheng ^a   Duan, Hongxia ^a   Liu, Dan ^a   Wang, Ping ^a   Yang, Jing ^b   Song, Lina ^a   Feng, Jing ^a   Yang, Dongling ^a   Qin, Zhihai ^a   Yan, Xiyun ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AA 98; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; CD146 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AA98; MONOCLONAL ANTIBODY V1Q; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; V 1Q; ANTIBODY; DEXTRAN SULFATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL INTERACTION; COLITIS ASSOCIATED COLORECTAL CARCINOGENESIS; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; EXPERIMENTAL COLITIS; FEMALE; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ADHERENCE; LYMPHOCYTE DIFFERENTIATION; MONOTHERAPY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; COLITIS; COLORECTAL NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD146; CARCINOGENESIS; CELL COMMUNICATION; COLITIS; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LEUKOCYTES; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84899618291     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.031     Document Type: Article

References (46)

1. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
2. S. Danese, and A. Mantovani Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer Oncogene 29 2010 3313 3323
3. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2011 573 621
4. J. Askling, P.W. Dickman, P. Karlen, O. Brostrom, A. Lapidus, R. Lofberg, and A. Ekbom Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study Lancet 357 2001 262 266
5. J. Terzic, S. Grivennikov, E. Karin, and M. Karin Inflammation and colon cancer Gastroenterology 138 2010 2101 2114.e5
6. F.R. Greten, L. Eckmann, T.F. Greten, J.M. Park, Z.W. Li, L.J. Egan, M.F. Kagnoff, and M. Karin IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296
7. B.K. Popivanova, K. Kitamura, Y. Wu, T. Kondo, T. Kagaya, S. Kaneko, M. Oshima, C. Fujii, and N. Mukaida Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis J Clin Invest 118 2008 560 570
8. M.J. Waldner, S. Wirtz, A. Jefremow, M. Warntjen, C. Neufert, R. Atreya, C. Becker, B. Weigmann, M. Vieth, S. Rose-John, and M.F. Neurath VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer J Exp Med 207 2010 2855 2868
9. S. Danese, M. Sans, D.M. Spencer, I. Beck, F. Donate, M.L. Plunkett, C. de la Motte, R. Redline, D.E. Shaw, A.D. Levine, A.P. Mazar, and C. Fiocchi Angiogenesis blockade as a new therapeutic approach to experimental colitis Gut 56 2007 855 862
10. Z. Huang, L. Zuo, Z. Zhang, J. Liu, J. Chen, L. Dong, and J. Zhang 3,3'-Diindolylmethane decreases VCAM-1 expression and alleviates experimental colitis via a BRCA1-dependent antioxidant pathway Free Radic Biol Med 50 2011 228 236
11. T. Taniguchi, H. Tsukada, H. Nakamura, M. Kodama, K. Fukuda, T. Saito, M. Miyasaka, and Y. Seino Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats J Gastroenterol Hepatol 13 1998 945 949
12. E. Rijcken, R.B. Mennigen, S.D. Schaefer, M.G. Laukoetter, C. Anthoni, H.U. Spiegel, M. Bruewer, N. Senninger, and C.F. Krieglstein PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis Am J Physiol Gastrointest Liver Physiol 293 2007 G446 G452
13. S. Farkas, M. Hornung, C. Sattler, K. Edtinger, M. Steinbauer, M. Anthuber, H.J. Schlitt, H. Herfarth, and E.K. Geissler Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis Int J Colorectal Dis 21 2006 71 78
14. A. Ouhtit, R.L. Gaur, Z.Y. Abd Elmageed, A. Fernando, R. Thouta, A.K. Trappey, M.E. Abdraboh, H.I. El-Sayyad, P. Rao, and M.G. Raj Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146 Biochim Biophys Acta 1795 2009 130 136
15. P. Bu, L. Gao, J. Zhuang, J. Feng, D. Yang, and X. Yan Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation Mol Cancer Ther 5 2006 2872 2878
16. P. Bu, J. Zhuang, J. Feng, D. Yang, X. Shen, and X. Yan Visualization of CD146 dimerization and its regulation in living cells Biochim Biophys Acta 1773 2007 513 520
17. C. Zheng, Y. Qiu, Q. Zeng, Y. Zhang, D. Lu, D. Yang, J. Feng, and X. Yan Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization Int J Biochem Cell Biol 41 2009 2163 2172
18. J. Zhuang, T. Jiang, D. Lu, Y. Luo, C. Zheng, J. Feng, D. Yang, C. Chen, and X. Yan NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction Free Radic Biol Med 49 2011 227 236
19. T. Jiang, J. Zhuang, H. Duan, Y. Luo, Q. Zeng, K. Fan, H. Yan, D. Lu, Z. Ye, J. Hao, J. Feng, D. Yang, and X. Yan CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis Blood 120 2012 2330 2339
20. Y. Luo, C. Zheng, J. Zhang, D. Lu, J. Zhuang, S. Xing, J. Feng, D. Yang, and X. Yan Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration Oncogene 31 2012 306 321
21. Q. Zeng, W. Li, D. Lu, Z. Wu, H. Duan, Y. Luo, J. Feng, D. Yang, L. Fu, and X. Yan CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer Proc Natl Acad Sci U S A 109 2012 1127 1132
22. X. Yan, Y. Lin, D. Yang, Y. Shen, M. Yuan, Z. Zhang, P. Li, H. Xia, L. Li, D. Luo, Q. Liu, K. Mann, and B.L. Bader A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth Blood 102 2003 184 191
23. G. Tsiolakidou, I.E. Koutroubakis, M. Tzardi, and E.A. Kouroumalis Increased expression of VEGF and CD146 in patients with inflammatory bowel disease Dig Liver Dis 40 2008 673 679
24. N. Bardin, D. Reumaux, K. Geboes, J.F. Colombel, M. Blot-Chabaud, J. Sampol, P. Duthilleul, and F. Dignat-George Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease Inflamm Bowel Dis 12 2006 16 21
25. M. Neidhart, R. Wehrli, P. Bruhlmann, B.A. Michel, R.E. Gay, and S. Gay Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis Arthritis Rheum 42 1999 622 630
26. L. Daniel, N. Bardin, V. Moal, F. Dignat-George, Y. Berland, and D. Figarella-Branger Tubular CD146 expression in nephropathies is related to chronic renal failure Nephron 99 2005 e105 e111
27. L. Feng, C. Matsumoto, A. Schwartz, A.M. Schmidt, D.M. Stern, and J. Pile-Spellman Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis Diabetes Care 28 2005 379 384
28. Y. Zhang, C. Zheng, J. Zhang, D. Yang, J. Feng, D. Lu, and X. Yan Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146 Hybridoma 27 2008 345 352
29. M.J. Jansen, T. Hendriks, R. Hermsen, J.W. Van der Meer, and R.J. Goris A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome Cytokine 10 1998 904 910
30. Y. Kang, F. Wang, J. Feng, D. Yang, X. Yang, and X. Yan Knockdown of CD146 reduces the migration and proliferation of human endothelial cells Cell Res 16 2006 313 318
31. H. Duan, S. Xing, Y. Luo, L. Feng, I. Gramaglia, Y. Zhang, D. Lu, Q. Zeng, K. Fan, J. Feng, D. Yang, Z. Qin, P.O. Couraud, I.A. Romero, B. Weksler, and X. Yan Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS Sci Rep 3 2013 1687
32. S. Wirtz, C. Neufert, B. Weigmann, and M.F. Neurath Chemically induced mouse models of intestinal inflammation Nat Protoc 2 2007 541 546
33. F. Obermeier, G. Kojouharoff, W. Hans, J. Scholmerich, V. Gross, and W. Falk Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice Clin Exp Immunol 116 1999 238 245
34. C. Moolenbeek, and E.J. Ruitenberg The "Swiss roll": a simple technique for histological studies of the rodent intestine Lab Anim 15 1981 57 59
35. P.B. Vermeulen, G. Gasparini, S.B. Fox, C. Colpaert, L.P. Marson, M. Gion, J.A. Belien, R.M. de Waal, E. Van Marck, E. Magnani, N. Weidner, A.L. Harris, and L.Y. Dirix Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours Eur J Cancer 38 2002 1564 1579
36. B. Weigmann, I. Tubbe, D. Seidel, A. Nicolaev, C. Becker, and M.F. Neurath Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue Nat Protoc 2 2007 2307 2311
37. I. Monteleone, F. Pallone, and G. Monteleone Th17-related cytokines: new players in the control of chronic intestinal inflammation BMC Med 9 2011 122
38. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J Exp Med 182 1995 1281 1290
39. M.F. Neurath, S. Pettersson, K.H. Meyer zum Buschenfelde, and W. Strober Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice Nat Med 2 1996 998 1004
40. M. Fukata, Y. Hernandez, D. Conduah, J. Cohen, A. Chen, K. Breglio, T. Goo, D. Hsu, R. Xu, and M.T. Abreu Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors Inflamm Bowel Dis 15 2009 997 1006
41. P.K. Dagur, A. Biancotto, L. Wei, H.N. Sen, M. Yao, W. Strober, R.B. Nussenblatt, and J. Philip McCoy Jr. MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases J Autoimmun 37 2011 319 327
42. A. Kratzer, H.W. Chu, J. Salys, Z. Moumen, M. Leberl, R. Bowler, C. Cool, M. Zamora, and L. Taraseviciene-Stewart Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD J Pathol 230 2013 388 398
43. Q. Wu, S.R. Case, M.N. Minor, D. Jiang, R.J. Martin, R.P. Bowler, J. Wang, J. Hartney, A. Karimpour-Fard, and H.W. Chu A novel function of MUC18: amplification of lung inflammation during bacterial infection Am J Pathol 182 2013 819 827
44. K. Nakamura, K. Honda, T. Mizutani, H. Akiho, and N. Harada Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules World J Gastroenterol 12 2006 4628 4635
45. S. Ghosh, and R. Panaccione Anti-adhesion molecule therapy for inflammatory bowel disease Therap Adv Gastroenterol 3 2010 239 258
46. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186